| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 3 | +33.33% | -0.59% | -0.54% | -0.05% | -4.63% | — |
| 14d | 3 | +33.33% | +9.44% | -1.90% | +11.33% | -1.01% | — |
| 30d | 3 | +33.33% | +1.36% | -3.60% | +4.97% | -25.72% | — |
| 60d | 3 | +33.33% | -2.59% | -3.15% | +0.56% | -27.84% | — |
| 90d | 3 | +33.33% | -9.24% | -4.04% | -44.98% | -44.98% | — |
| 180d | 3(1 pending) | +0.00% | +48.30% | +7.50% | +40.80% | +40.80% | — |
| 1y | 3(1 pending) | +50.00% | +177.10% | +16.34% | +160.76% | +160.76% | — |
| 2y | 3(3 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| OVID OVID THERAPEUTICS INC. | PURCHASEGRANT Stock grant | 1,435,000 | — | — | 1,435,000 | Feb 26, 2026 | Mar 2, 2026 ↗ | View → |
| OVID OVID THERAPEUTICS INC. | SALE President and CEO | 11,656 | $1.45 | $16.9K | 61,750 | Feb 23, 2026 | Mar 2, 2026 ↗ | View → |
| OVID OVID THERAPEUTICS INC. | PURCHASEGRANT Stock grant | 890,000 | — | — | 890,000 | Jan 4, 2026 | Jan 5, 2026 ↗ | View → |
| OVID OVID THERAPEUTICS INC. | SALE President and COO | 5,279 | $0.56 | $3.0K | 73,406 | Feb 26, 2025 | Feb 28, 2025 ↗ | View → |
| OVID OVID THERAPEUTICS INC. | PURCHASEGRANT Stock grant | 43,750 | — | — | 78,685 | Feb 20, 2025 | Feb 24, 2025 ↗ | View → |
| OVID OVID THERAPEUTICS INC. | PURCHASEGRANT Stock grant | 262,500 | — | — | 262,500 | Feb 20, 2025 | Feb 24, 2025 ↗ | View → |
| OVID OVID THERAPEUTICS INC. | PURCHASE President and COO | 6,810 | $0.73 | $5.0K | 34,935 | Jan 27, 2025 | Jan 29, 2025 ↗ | View → |
| OVID OVID THERAPEUTICS INC. | PURCHASEGRANT Stock grant | 140,000 | — | — | 140,000 | Sep 9, 2024 | Sep 11, 2024 ↗ | View → |